Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019056-13-001224
Filing Date
2013-11-06
Accepted
2013-11-06 11:47:54
Documents
2
Period of Report
2013-11-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT acelrx_4.html 4  
1 OWNERSHIP DOCUMENT acelrx_4.xml 4 11851
2 EXHIBIT 24 ex_24.txt EX-24 1276
  Complete submission text file 0001019056-13-001224.txt   15655
Mailing Address PERCEPTIVE ADVISORS LLC 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
EDELMAN JOSEPH (Reporting) CIK: 0001164426 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 131195357

Mailing Address 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 646-205-5340
PERCEPTIVE ADVISORS LLC (Reporting) CIK: 0001224962 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 131195358

Mailing Address C/O PERCEPTIVE ADVISORS LLC 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address C/O PERCEPTIVE ADVISORS LLC 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 646-205-5340
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting) CIK: 0001249675 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 131195356

Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Issuer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations